ArticleJournal of clinical microbiology2013
Development and evaluation of a novel, semiautomated Clostridium difficile typing platform.
Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.mSphere · 2021Trial
- Molecular epidemiology ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Multi-omics investigation ofeLife · 2022Article
- Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.The Journal of clinical investigation · 2019Article
- Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.Infection control and hospital epidemiology · 2018Article
- Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.Journal of clinical microbiology · 2017Article
- An Evaluation of Food as a Potential Source for Clostridium difficile Acquisition in Hospitalized Patients.Infection control and hospital epidemiology · 2016Article
- Ceftolozane-tazobactam activity against phylogenetically diverse Clostridium difficile strains.Antimicrobial agents and chemotherapy · 2015Article
- Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.Antimicrobial agents and chemotherapy · 2015Article
- Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.Journal of clinical microbiology · 2014Article
- Prevalence and risk factors for asymptomatic Clostridium difficile carriage.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014Article
- Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Clinical microbiology reviews · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
We describe a novel, semiautomated Clostridium difficile typing platform that is based on PCR-ribotyping in conjunction with a semiautomated molecular typing system. The platform is reproducible with minimal intra- or interassay variability. This method exhibited a discriminatory index of 0.954 and is therefore comparable to more arduous typing systems, such as pulsed-field gel electrophoresis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.